SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001214659-17-002020
Filing Date
2017-03-16
Accepted
2017-03-16 16:22:38
Documents
3
Period of Report
2017-04-27
Effectiveness Date
2017-03-16

Document Format Files

Seq Description Document Type Size
1 p315170def14a.htm DEF 14A 1058171
2 antheralogo.jpg GRAPHIC 6630
3 chart1.jpg GRAPHIC 126557
  Complete submission text file 0001214659-17-002020.txt   1242823
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34637 | Film No.: 17694846
SIC: 2834 Pharmaceutical Preparations